Literature DB >> 35859539

Palliative care implementation in neuro-oncology-Where do we come from, where do we go?

Caroline Hertler1.   

Abstract

Entities:  

Year:  2022        PMID： 35859539      PMCID： PMC9290898          DOI： 10.1093/nop/npac039

Source DB:  PubMed          Journal:  Neurooncol Pract        ISSN： 2054-2577


× No keyword cloud information.
  8 in total

Review 1.  Integration of palliative care into the neuro-oncology practice: patterns in the United States.

Authors:  Tobias Walbert
Journal:  Neurooncol Pract       Date:  2014-03

Review 2.  The end-of-life phase of high-grade glioma patients: a systematic review.

Authors:  Eefje M Sizoo; H Roeline W Pasman; Linda Dirven; Christine Marosi; Wolfgang Grisold; Günther Stockhammer; Jonas Egeter; Robin Grant; Susan Chang; Jan J Heimans; Luc Deliens; Jaap C Reijneveld; Martin J B Taphoorn
Journal:  Support Care Cancer       Date:  2013-12-14       Impact factor: 3.603

3.  Integration of Palliative Care Into Standard Oncology Care: ASCO Clinical Practice Guideline Update Summary.

Authors:  Betty R Ferrell; Jennifer S Temel; Sarah Temin; Thomas J Smith
Journal:  J Oncol Pract       Date:  2016-11-01       Impact factor: 3.840

4.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

5.  A proposed framework of supportive and palliative care for people with high-grade glioma.

Authors:  Jennifer Philip; Anna Collins; Caroline Brand; Vijaya Sundararajan; Carrie Lethborg; Michelle Gold; Rosalind Lau; Gaye Moore; Michael Murphy
Journal:  Neuro Oncol       Date:  2018-02-19       Impact factor: 12.300

Review 6.  European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma.

Authors:  Andrea Pace; Linda Dirven; Johan A F Koekkoek; Heidrun Golla; Jane Fleming; Roberta Rudà; Christine Marosi; Emilie Le Rhun; Robin Grant; Kathy Oliver; Ingela Oberg; Helen J Bulbeck; Alasdair G Rooney; Roger Henriksson; H Roeline W Pasman; Stefan Oberndorfer; Michael Weller; Martin J B Taphoorn
Journal:  Lancet Oncol       Date:  2017-06       Impact factor: 54.433

Review 7.  Determining medical decision-making capacity in brain tumor patients: why and how?

Authors:  Andrea Pace; Johan A F Koekkoek; Martin J van den Bent; Helen J Bulbeck; Jane Fleming; Robin Grant; Heidrun Golla; Roger Henriksson; Simon Kerrigan; Christine Marosi; Ingela Oberg; Stefan Oberndorfer; Kathy Oliver; H Roeline W Pasman; Emilie Le Rhun; Alasdair G Rooney; Roberta Rudà; Simone Veronese; Tobias Walbert; Michael Weller; Wolfgang Wick; Martin J B Taphoorn; Linda Dirven
Journal:  Neurooncol Pract       Date:  2020-07-16

Review 8.  Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative.

Authors:  Linda Dirven; Maartje E Vos; Tobias Walbert; Terri S Armstrong; David Arons; Martin J van den Bent; Jaishri Blakeley; Paul D Brown; Helen Bulbeck; Susan M Chang; Corneel Coens; Mark R Gilbert; Robin Grant; Rakesh Jalali; Danielle Leach; Heather Leeper; Tito Mendoza; Lakshmi Nayak; Kathy Oliver; Jaap C Reijneveld; Emilie Le Rhun; Larry Rubinstein; Michael Weller; Patrick Y Wen; Martin J B Taphoorn
Journal:  Neurooncol Pract       Date:  2021-02-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.